The latest closing stock price for Contineum Therapeutics as of January 31, 2025 is 9.79.
An investor who bought $1,000 worth of Contineum Therapeutics stock at the IPO in 2024 would have $-364 today, roughly 0 times their original investment - a -36.43% compound annual growth rate over 1 years.
The all-time high Contineum Therapeutics stock closing price was 21.75 on July 16, 2024.
The Contineum Therapeutics 52-week high stock price is 22.00, which is 124.7% above the current share price.
The Contineum Therapeutics 52-week low stock price is 9.76, which is 0.3% below the current share price.
The average Contineum Therapeutics stock price for the last 52 weeks is 16.59.
An investor who bought $1,000 worth of Contineum Therapeutics stock at the IPO in 2024 would have $-364 today, roughly 0 times their original investment - a -36.43% compound annual growth rate over 1 years.
The all-time high Contineum Therapeutics stock closing price was 21.75 on July 16, 2024.
The Contineum Therapeutics 52-week high stock price is 22.00, which is 124.7% above the current share price.
The Contineum Therapeutics 52-week low stock price is 9.76, which is 0.3% below the current share price.
The average Contineum Therapeutics stock price for the last 52 weeks is 16.59.